Cornea

Skip Navigation LinksHome > September 2014 - Volume 33 - Issue 9 > Mitomycin-C for Mucous Membrane Overgrowth in OOKP Eyes
Cornea:
doi: 10.1097/ICO.0000000000000183
Case Report

Mitomycin-C for Mucous Membrane Overgrowth in OOKP Eyes

Avadhanam, Venkata S. MS, FRCS, FRCOphth*,†; Herold, Jim FDRCS (Eng), FRCS (Ed), FRCS (Eng); Thorp, Simon MBChB, DA, MRCA, FCARCSI, FFPMCAI; Liu, Christopher S. C. FRCOphth*,†,§

Collapse Box

Abstract

Purpose: The aim of this study was to report the use of mitomycin-C (MMC) in the treatment of mucous membrane overgrowth in eyes with osteo-odonto-keratoprosthesis (OOKP).

Methods: Records of 4 cases with mucous membrane overgrowth after stage 2 OOKP surgery were reviewed.

Results: All the patients had undergone a mucous membrane trimming procedure followed by MMC application. None of the patients had any episode of recurrence of the mucous membrane overgrowth after a single application of MMC in the follow-up period that ranged from 1 to 11 years.

Conclusions: MMC can successfully arrest mucous membrane overgrowth in OOKP-implanted eyes including refractory cases.

© 2014 by Lippincott Williams & Wilkins.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.